Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bremner

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
ANZ Journal of Surgery|October 4, 2003
Is there an association between chronic lung disease and abdominal aortic aneurysm expansion?Carole Spencer, Konrad Jamrozik, Shane Kelly, et al.
Communicable Diseases Intelligence Quarterly Report|November 25, 2010
Zoonotic tuberculosis: on the declinePaul R Ingram, Peter Bremner, Tim J Inglis, et al.
Allergy & Rhinology (Providence, R.I.)|July 7, 2017
A patient preference study that evaluated fluticasone furoate and mometasone furoate nasal sprays for allergic rhinitisAnahi Yanez, Alex Dimitroff, Peter Bremner, et al.
Thorax|April 5, 2015
Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study, a randomised controlled trialPeter A Frith, Philip J Thompson, Rajeev Ratnavadivel, et al.
Lancet (London, England)|May 18, 2026
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trialsAlberto Papi, Neil J Greening, Surya P Bhatt, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
ANZ Journal of Surgery|October 4, 2003
Is there an association between chronic lung disease and abdominal aortic aneurysm expansion?Carole Spencer, Konrad Jamrozik, Shane Kelly, et al.
Communicable Diseases Intelligence Quarterly Report|November 25, 2010
Zoonotic tuberculosis: on the declinePaul R Ingram, Peter Bremner, Tim J Inglis, et al.
Allergy & Rhinology (Providence, R.I.)|July 7, 2017
A patient preference study that evaluated fluticasone furoate and mometasone furoate nasal sprays for allergic rhinitisAnahi Yanez, Alex Dimitroff, Peter Bremner, et al.
Thorax|April 5, 2015
Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study, a randomised controlled trialPeter A Frith, Philip J Thompson, Rajeev Ratnavadivel, et al.
Lancet (London, England)|May 18, 2026
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trialsAlberto Papi, Neil J Greening, Surya P Bhatt, et al.
Pageof 1